The repository’s unique features include:
- Empowering users to create aliquots
- The ability to perform assay testing on a range of different specimen types
- Automated routing of specimens to various labs for testing
- Extensive cross linking with clinical trial data
- Built in IRB consent compliance
- Advanced query and reporting capabilities in order to provide investigators with efficient access to the data they need.
In accordance with the National Cancer Institute’s resource sharing policies, Saint John’s Cancer Institute is committed to making its melanoma specimen repository available for collaborative studies with external researchers. Investigators interested in obtaining specimens should email us a brief description of the type and number of specimens needed. If specimens are available, we will ask for a research proposal detailing the proposed use of the specimens and justification for sample size. Proposals are reviewed based on clinical and scientific import, preliminary data, statistical support showing feasibility, and demonstration that use of this unique and limited resource is crucial to the research proposed.
Evidence of funding is not required to submit a proposal but must be obtained before specimens can be released. In addition, the authorization for use of specimens is not considered final until the applicant signs a specimen use agreement to comply with standard procedures for data analysis, data confidentiality, authorship, and intellectual property sharing. Finally, evidence of IRB approval for the proposal is required before release of samples.
Requests for specimen amounts that would exhaust the repository supply or curtail specimen access by Saint John’s Cancer Institute investigators will not be honored. Specimens are provided for research purposes only. Specimens and their products shall not be sold (or distributed free of charge) to third parties.